# A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.

> **NCT07090486** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 14000 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** nirmatrelvir-ritonavir

## Key facts

- **NCT ID:** NCT07090486
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-15
- **Primary completion:** 2025-04-15
- **Final completion:** 2025-04-15
- **Target enrollment:** 14000 (ACTUAL)
- **Last updated:** 2025-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07090486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07090486, "A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07090486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*